Study of Early Warning Efficiency of Different Laboratory Markers in Predicting Progression of Disease in COVID-19

被引:0
|
作者
Krishnamurthy, Vishwanath [1 ]
Suhail, K. Mohammed [1 ]
Aslam, S. Shaikh Mohammed [1 ]
Raj, Madhu P. [1 ]
Patil, Prashanth [1 ]
Phaniraj, Priyanka [1 ]
机构
[1] MS Ramaiah Med Coll & Hosp, Dept Internal Med, Bengaluru, Karnataka, India
关键词
C reactive protein; early warning efficiency; Eosinopenia; progression of disease in COVID-19;
D O I
10.4103/aam.aam_117_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: COVID 19 pandemic has given rise to several challenges to clinicians and one of the keys in this is to predict the set of patients who progress from mild disease to moderate and severe. Apart from the symptomatology and signs, there are several lab parameters varying from biochemical, hematological to radiological parameters which help us in stratifying the stage of disease and also in deciding on which set of patients need close and vigilant monitoring. This would help us in better stratification of disease and utilize the available infrastructure and resources in an optimum way for better management of the disease. Aim: To analyze the early warning efficiency of laboratory parameters individually or in combination in predicting the progress of disease in patients from mild to moderate/severe disease. Materials and Methods: This was taken up as a retrospective study with 100 cases and 100 controls. The demographic details, inflammatory markers, biochemical markers and hematological markers were analyzed. Test of significance was employed to compare categorical variables while student t-test was employed to test the difference in the mean value such as age between case and control (Mann-Whitney U-test in parameters not having normal distribution). Receiver operating characteristic (ROC) curve was constructed for these parameters using cases and controls and area under the curve (AUC) were estimated which was used as an indicator of sensitivity and specificity of the parameter in their early warning efficiency. The critical values for each of the parameters either individually or in combination was estimated as well. Results: Among the parameters C reactive protein (CRP), d-dimers and eosinopenia have the best early warning efficiency. The area under the ROCs curve for neutrophil lymphocyte ratio (NLR), CRP. Ferritin, lactate dehydrogenase, Eosinopenia was 0.609, 0.947, 0.614, 0.554, 0.617 respectively at triage. However, a combination of eosinopenia with CRP (AUC-0.732) or NLR with CRP (AUC-0.728) have a good sensitivity and specificity in predicting the outcome regarding the progression of the disease. Conclusions: Among the parameters, CRP, d-dimers, Eosinopenia and NLR have the best early warning efficiency. However, a combination of Eosinopenia and CRP at triage should also serve as a red flag sign in patients apart from the well-known NLR and IL6 values.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 50 条
  • [41] Case series: Failure of imaging & biochemical markers to capture disease progression in COVID-19
    Dorey-Stein, Zachariah L.
    Myers, Catherine N.
    Kumaran, Maruti
    Mamary, Albert J.
    Criner, Gerard J.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [42] Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
    Fathalla, Lamiaa A.
    Kamal, Lamyaa M.
    Salaheldin, Omina
    Khalil, Mahmoud A.
    Kamel, Mahmoud M.
    Fahim, Hagar H.
    Abdel-Moneim, Youssef A. S.
    Abdulhakim, Jawaher A.
    Abdel-Moneim, Ahmed S.
    El-Meligui, Yomna M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
  • [43] New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression
    Liu, Nan
    Long, Hui
    Sun, Jianhua
    Li, Huan
    He, Yunting
    Wang, Qiang
    Pan, Kai
    Tong, Yongliang
    Wang, Bingshun
    Wu, Qingming
    Gong, Likun
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (07) : 3112 - 3120
  • [44] Initial complete blood count score and predicting disease progression in COVID-19 patients
    Ozbalak, Murat
    Besisik, Sevgi Kalayoglu
    Tor, Yavuz Burak
    Medetalibeyoglu, Alpay
    Kose, Murat
    Senkal, Naci
    Aksoy, Elif
    Cagatay, Atahan
    Erelel, Mustafa
    Gul, Ahmet
    Esen, Figen
    Yavuz, Serap Simsek
    Alkac, Ummuhan Isoglu
    Tukek, Tufan
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (01): : 77 - 83
  • [45] The Impact of COVID-19 Infection on Prognostic Effect of Liver Laboratory Markers and Disease Outcome
    Ghamyes, Randa R.
    Alhamadani, Hayjaa M.
    Rasool, Mohammed, I
    ASIAN JOURNAL OF WATER ENVIRONMENT AND POLLUTION, 2022, 19 (05) : 37 - 42
  • [46] Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning
    Sun, Chenxi
    Hong, Shenda
    Song, Moxian
    Li, Hongyan
    Wang, Zhenjie
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [47] Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning
    Chenxi Sun
    Shenda Hong
    Moxian Song
    Hongyan Li
    Zhenjie Wang
    BMC Medical Informatics and Decision Making, 21
  • [48] Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital
    Punzalan, Felix Eduardo R.
    Aherrera, Jaime Alfonso M.
    de Paz-Silava, Sheriah Laine M.
    Mondragon, Alric V.
    Malundo, Anna Flor G.
    Tan, Joanne Jennifer E.
    Tantengco, Ourlad Alzeus G.
    Quebral, Elgin Paul B.
    Uy, Mary Nadine Alessandra R.
    Lintao, Ryan C. V.
    Dela Rosa, Jared Gabriel L.
    Mercado, Maria Elizabeth P.
    Avenilla, Krisha Camille
    Poblete, Jonnel B.
    Albay Jr, Albert B.
    David-Wang, Aileen S.
    Alejandria, Marissa M.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Predicting Mortality for COVID-19 Patients Admitted to an Emergency Department Using Early Warning Scores in Poland
    Rzonca, Patryk
    Butkiewicz, Slawomir
    Dobosz, Paula
    Zaczynski, Artur
    Podgorski, Marcin
    Galazkowski, Robert
    Wierzba, Waldemar
    Zycinska, Katarzyna
    HEALTHCARE, 2024, 12 (06)
  • [50] The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients
    Platzer, Moritz
    Totschnig, David
    Karolyi, Mario
    Clodi-Seitz, Tamara
    Wenisch, Christoph
    Zoufaly, Alexander
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (15-16) : 458 - 464